FDA greenlights first clinical trials of Elon Musk’s human brain implants
By Belle Carter // May 30, 2023

Neuralink, Elon Musk's neurotechnology company, recently obtained approval from the Food and Drug Administration (FDA) to conduct a clinical study of brain implants in humans. This marks the first in-human clinical study for the company.

"This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," the company said in a statement. "Recruitment is not yet open for our clinical trial. We'll announce more information on this soon."

Project officials said they are "currently focused on giving people with quadriplegia the ability to control their computers and mobile devices with their thoughts."

Musk has been insisting that his devices are safe and could help solve conditions, such as obesity, autism, depression and schizophrenia. The tech mogul even volunteered his kids as guinea pigs.

The FDA initially turned down the company in 2019 as there are major issues involving the implant's lithium battery, the possibility of its wires migrating within the brain and whether the device could be safely removed without damaging brain tissue.

According to reports, the implant prototypes, which are the size of a coin, have so far been implanted in the skulls of monkeys. With the help of a surgical robot in a demonstration back in April 2021, a piece of the skull was replaced with a disk and wires were strategically inserted into the brain of a nine-year-old macaque named Pager.

Musk said the disk registered nerve activity, relaying the information via a common Bluetooth wireless signal to a device such as a smartphone. "It actually fits quite nicely in your skull," Musk said during a prior presentation. "It could be under your hair and you wouldn't know." The technology has also been tested on pigs whose legs can be controlled remotely by a computer.

Human knowledge is under attack! Governments and powerful corporations are using censorship to wipe out humanity's knowledge base about nutrition, herbs, self-reliance, natural immunity, food production, preparedness and much more. We are preserving human knowledge using AI technology while building the infrastructure of human freedom. Speak freely without censorship at the new decentralized, blockchain-power Brighteon.io. Explore our free, downloadable generative AI tools at Brighteon.AI. Support our efforts to build the infrastructure of human freedom by shopping at HealthRangerStore.com, featuring lab-tested, certified organic, non-GMO foods and nutritional solutions.

Meanwhile, the Department of Transportation announced in February that it is investigating whether the company had transported potentially dangerous pathogens when removing the brain chips from monkeys' brains without proper measures to contain them, which would be in violation of federal law.

Another probe by the U.S. Department of Agriculture's (USDA) Office of Inspector General was conducted for potentially violating the Animal Welfare Act. The probe was also checking on how the USDA has been overseeing the company.

Reuters report in December 2022 indicated that California-based Neuralink, which employs more than 400, has raised at least $363 million and already killed about 1,500 animals, including more than 280 sheep, pigs and monkeys for research since 2018.

Musk has plenty of competitors in hijacking human brains

Musk's company aims to supercharge human capabilities, treat neurological disorders and ultimately achieve a symbiotic relationship between humans and artificial intelligence. However, Neuralink is not the sole company working on similar brain-machine or brain-computer interface research.

Its archrival Synchron announced in July 2022 that it had implanted the first human brain-machine interface in the United States. Its implant version does not require cutting into the skull to install it, unlike Neuralink's. (Related: Neuralink competitor Synchron launches human trials for first commercial brain computer interface.)

Another implant project, but this one designed only for research purposes, is from the company Blackrock Neurotech. It has also received FDA approval for human testing. Its founder is Musk's Neuralink co-founder Max Hodak, who split with the Twitter CEO and raised venture capital for his own project at a startup called Science.

Other companies seeking to make a play in the sector include BrainCo, Kernel and CTRL-Labs, now a part of Meta's virtual reality division.

Visit Transhumanism.news for more news about transforming human beings.

Watch the video below that talks about the FDA approval of Neuralink's brain chips for human testing.

This video is from the InfoWars channel on Brighteon.com.

More related stories:

Utah-based Blackrock Neurotech has already microchipped at least 50 people – transhumanism in action.

Ethical questions raised after Elon Musk's Neuralink company implants chip in monkey's brain.

Latest B.S. science hype from Elon Musk claims upcoming launch of "brain-computer interface" called Neuralink.

Globalists push transhumanism agenda with computer chips inserted into humans via COVID injections.

Yuval Noah Harari: Humans are now HACKABLE ANIMALS thanks to vaccines.

Sources include:






Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Embed article link:
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.